The U.S. speech therapy market is estimated to be valued at US$ 4.83 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The U.S. speech therapy market focuses on offering services related to the diagnosis and treatment of speech disorders. Speech therapy aims to treat conditions such as speech impairments caused by deafness, cerebral palsy, stroke, brain injury, Parkinson's disease, cleft lip and palate, and developmental delay. It involves identifying and strengthening areas where communication is being affected. Speech therapists use different techniques and activities to help patients improve their ability to communicate.

Market Dynamics:
The growth of the U.S. speech therapy market is majorly driven by the increasing prevalence of speech disorders in the region. For instance, according to CDC, around 2-3 out of 100 children aged 3 to 17 suffer from a speech or language disorder. Also, approximately 7.5 million Americans have impaired ability to speak. Additionally, growing geriatric population is also expected to fuel the market growth as older people are more susceptible to conditions requiring speech therapies such as Parkinson's disease and stroke. Furthermore, rising awareness about benefits of speech therapy for treating various cognitive and developmental conditions in children as well as adults is aiding the market growth.

For more insights, read- http://insightfulmarket.weebly.com/blog/telehealth-speech-therapy-is-fastest-growing-segment-fueling-the-growth-of-us-speech-therapy-market